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\ ot all tobacco has to go up inl
Vsmoke. Anticipating a diminishing
market for cigarettes and other such
tobacco products in the future, researchers
around the United States are studying alter-
native uses for tobacco plants. If the
research comes to fruition, perhaps tobacco
farmers may not have to change their OCCU-
pation, just their customers.
Currently, it looks as though biotechnol-
ogy companies could be future customers of
tobacco farmers. The most promising field
of research for alternative uses of tobacco
involves the genetic engineering of tobacco
plants to produce various substances, such as
industrial chemicals, pharmaceuticals, anid
consumer product ingredients.
The Chosen
Crop
Besides the fact
that health aware-
ness and legislation
are dictating that the
time is right to explore
tobacco alternatives, tobac-
co rust happens to be an ideal
plant to genetically manipulate.
Mans iresearchers have called
tobacco the "white rat" and the
I
"fruit fly" ofthe plant king-
dom, comparing it to tradi-
tional laboratory animals used
for genetic bioengineering.
"Tobacco has been chosen
for good reason," says
' Carole Cramer, a profes-
sor ofplant pathology and
physiology at Virginia Poly-
technic Institute anid %tate
University in BlacksbLurg.
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In order to genetically engineer a plant,
Cramer says the desired genes must first be
introduced into the plant's cells. Then the
cells must be enticed to reproduce a whole
plant. Researchers have found that tobacco
is the easiest plant to successfully genetical-
ly engineer.
In addition, Cramer says, "Tobacco is an
amazing biomass producer. A seed smaller
than the head of a pin can produce plants
that are four to six feet tall. Tobacco has also
been optimized for leaf growth."
Furthermore, tobacco has a high yield of
seeds perplant; a single plant can yield up to
one million seeds. Cramer says that geneti-
cally engineered seeds could produce many
acres from the first generation. All these fac-
tors suggest that genetically engineered
tobacco crops would be relatively easy to
maintain, and that they would flourish in a
short amount oftime, Cramer says.
Acres of 3
Possibilities
There are count-
less possibilities for
tobacco, but cur-
rently the most
promising research
involves using the
plant to produce
/ vaccines, human
enzymes, and poly-
mers. While a
majority of the Newseedsto sow. Asingl
research has yet to up to one million seeds ti
be published and is transgenic crops.
guarded under intellectual property rights,
researchers are talking in general terms
about their work on the potential applica-
tions for transgenic tobacco products.
Tobacco and Health Research
Institute. A good example of the current
wave of new applications research can be
found at the Tobacco and Health
Research Institute (THRI), located at the
University ofKentucky in Lexington. The
institute was established in 1970 by the
Kentucky state legislature and is funded
by a $.005 tax on each pack of cigarettes
sold in Kentucky.
After more than two decades oftobac-
co-related medical research, the institute
has refocused its mission to emphasize the
development of new products based on
transgenic tobacco, creating new opportu-
nities for farmers and seeking industrial
partners to collaborate with the institute.
Maelor Davies, director ofthe THRI, says
the institute is helping to develop new
markets as well as new crops. THRI
researchers are looking at a variety of uses
for tobacco while continuing to investigate
the basic science ofplant bioengineering.
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Deane Falcone, an assistant professor of
metabolic engineering in the department of
agronomy and a faculty asssociate at the
THRI, is investigating tobacco's genetic
regulation to determine how the plant can
express its less abundant compounds in
greater amounts. He explains that specially
modified bacteria are commonly used for
introducing genetic material into tobacco.
Any harmful genetic material is removed
from the bacterium and the desired gene or
genes are introduced into it. The researchers
isolate the tobacco's leafcells and then culti-
vate the genetically engineered bacterium
together with the leaf cells. The bacterium
invades and infects the cells, thereby insert-
ing the new genes into the plant's cells.
Falcone and others are working to develop
promoters, orsections ofDNA that must be
coupled with a gene in order for the gene to
be expressed in the plant tissue.
The THRI is col-
laborating with sever-
*c ~. ~ al companies, includ-
I ing InterLink Assoc-
- E iates of Princeton,
New Jersey. Inter-
Link has developed
peptides for resis-
tance to plant dis-
eases such as tobacco
blue mold, and
researchers at the
THRI are attempt-
3bacco plant can yield ing to produce the
can be used to plant peptides in tobacco
on a large scale. In
1997, blue mold caused an estimated $165
million loss to farmers in Kentucky alone.
Davies says the peptides could be used in
agriculture as environmentally compatible
antibiotics, pesticides, and antifungal
sprays for fruits and vegetables. He says the
researchers are making good progress, and
that they are close to submitting results for
publication.
North Carolina State University.
Raymond Long, a professor of crop science
at North Carolina State University in
Raleigh, and colleagues have used tobacco
to express a gene protein in high concen-
trations and demonstrate its efficacy. In
studies, the researchers sought to express
bovine lysozyme, an enzyme with antibac-
terial properties that is well-suited for use
as a preservative in foods, cosmetics, and
agriculture, in transgenic tobacco plants.
The results, published in the July 1997
issue oftheJournalofAgriculturalandFood
Chemistry, showed that Long's group was
successful in expressing, isolating, and
purifying bovine lysozyme at high levels in
tobacco. "Certainly a wide range of com-
pounds can be expressed in tobacco, but
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not too many at high levels," Long 4
says. "This was a good case model."
Long's group is currently inves-
tigating the efficacy of a papilloma
virus vaccine that is produced by
the introduction of a gene into
tobacco plants. Papilloma strikes
humans and a wide range of ani-
mals. The human papilloma virus
causes a variety of warts on the
hands, feet, and genitalia, and 900
of cervical cancers are thought to
have their origins in the virus,
Long says. The researchers are first
testing a vaccine for canine oral
papilloma virus in dogs. Ifit is suc-
cessful, they plan to begin testing a
human papilloma virus vaccine to
combat genital warts in humans.
CropTech Development
Corporation. Promising research by
Cramer and colleagues led to the
creation of a company, CropTech
Development Corporation, also
located in Blacksburg. CropTech is
working to develop genetically
altered plants to make products
such as drugs and vaccines. "It's all
preclinical research and develop-
ment at this point," says Cramer.
She says three applications oftrans-
genic tobacco look especially
promising at this time. Growin
First, the company is using maintai
tobacco plants to produce a human
enzyme that could be used in the treat-
ment of Gaucher's disease, a rare genetic
disorder that affects about 2,000 people in
the United States each year, causing brittle
bones, distended abdomen, and in severe
cases, death. There is a treatment currently
available, but Cramer says its cost is often
prohibitively expensive.
Cultivating cures? (left to right) NC State Universit)
Boston, and Art Weissinger examine tobacco plants er
a vaccine for the papilloma virus.
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ined, making them ideal for producing new products.
Another promising application is the
development ofa cell cycle inhibitor, which
blocks cell growth. Cramer says this prod-
nct may be able to help prevent cancer.
Tlhird, Cramer and colleagues are investi-
gating a potential clot buster, or serum pro-
tein with anticoagulant properties, that she
says tobacco produces in a fully active form.
While much of the
= research is currently
confidential, Cramer
explains that CropTech
offers a unique
i approach to synthesiz- _I ing pharmaceutical
compounds in trans-
genic tobacco. She says
the gene inserted in the
plants is not actually
expressed until after the
I} t - plant is harvested. "We
can separate normal
plant growth from the
development of the
product," says Cramer.
Postharvest gene
y's Ray Long, Becky expression allows the
ngineered to produce researchers to synthe-
size products, such as
cell cycle inhibitors, that would be
detrimental to the plant during
growth.
Furthermore, Cramer says, this
process prevents degradation that
can occur when the protein is
exposed to temperature changes.
"As opposed to sitting out in a field
for weeks exposed tO the' sun,"- SheC
says, this process offeirs .a fresllN,
synthesized" conmpouLntd.
C'ropTech researchers al-e also
working with the L)epartment of
Defense to produce vaccine anitigens
against possible biological warfare
agents, Cramer says. Eventually, she
says, they will target edible vaccine
i strategies.
University of Central Florida
and Bioelastics Research. Henrv
Daniell, a Molecular genleticist at
the University of Central Florida inl
Orlando, and colleagues are investi-
gating the potential foi the use of
tobacco to prodtice proteini-based
polymers in collaboration wsith the
Birmingham, Alabam-iia~based
Bioelastics Research. Many plastics
are currently made from petroleum-
based polymers, the production of
which requires the use ofhazardous
_d and and toxic chemicals, incltiding
d and organic solvents such as hexane.
Many of these organic soIlents aIC
carcinogenic.
Genetically, engineering tobacco anid
other plants to gener-ate pi-oteiin-based
polymers, however, is nIoiC envionmen-
tally friendlyt because the productionI
process does nlot require hazardous chemi-
cals. Furthermore, scientists canl design the
polymers to be biodegradable bs
"installing" chemical clocks to determline
the polymers' half-lives.
Daniell's group has expressed polymers
derived fronm human elastini genes into
tobacco plants. Scientists at Bioelastics
have found that these comnpounds canl be
absorbed by the skin and are biocomiipati-
ble, which demonstrates their potential for
use in medical applicationis such as the pre-
vention of postsurgical adhesions (fibrous
tissue formed in response to surgical
manipulation ofinternal organs), as well as
in tissue reconstruction anid programmed
drug delivery. Bioelastics hopes to soon
begin conducting clinical trials on the use
of a polymer produced in z'scherichia coli
and tobacco for the preventioni of postsur-
gical adhesions.
Daniell believes the Imlost fihnanciallIN
promising use of tobacco, however, is the
production of it'.Lts and zccineP..
CurrentlI, insulill is prodCLedI it] n '. Co/i
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and then must be purified, a process that is
lengthy and that recovers small amounts,
making the end product very expensive,
Daniell says. Daniell and colleagues are
developing a one-step process in which
insulin is purified in tobacco. He says the
potential exists for tobacco to produce
large amounts of insulin. The researchers
are currently in the process of expressing
insulin in tobacco plant genes, and Daniell
says the insulin could be ready for clinical
trials next year. Daniell's lab is also using
tobacco to develop vaccines, induding one
for cholera, a disease that can cause diar-
rhea, dehydration, anddeath.
Implementation
There is concern about the introduction of
genetically manipulated plants into nature
because of the potential for foreign genes
to escape through pollen dispersal, but
Daniell says that tobacco is safe. Tobacco
plants mainly self-pollinate and there is no
evidence of any hybrids in nature.
Therefore, he says, there is little risk of
transfer ofgenetic material to otherplants.
While tobacco does have advantages
over other crops in the manufacture of
genetically engineered products, some
adjustments need to be made in order for
the plant to be competitive with other
crops. "We're trying to work out the kinks
oftobacco production in order for it to be
the plant of choice," says Davies.
"Certainly thepotential is there.'
One issue is that the production costs
of tobacco are much higher than the pro-
duction costs of other crops such as corn
and soybeans. The high costs are due to
tobacco's unusual production style, which
involves manual harvesting. The high price
that tobacco currently commands allows
farmers to support this high-cost produc-
tion style.
Davies says that to achieve lower pro-
duction costs, the development of new
varieties of tobacco will be pursued. "The
tobacco of the future will probably be
quite a different-looking crop than [that
of] today," he says. For example, THRI
researchers are working to extend the life
of tobacco leaves, thereby increasing the
production amount of genetically engi-
neered compounds.
Most important, however, Long says
more money is needed for further research.
"The failing is less in the science and tech-
nology, and more in funding," agrees Lou
Tornatzky, a senior fellow with the
Southern Technology Council, an organi-
zation based in Research Triangle Park,
North Carolina, that works to strengthen
the regional economy through the more
effective development, commercialization,
and deployment of technology. In March
1996, the group published a market analy-
sis, Prospectsfor Plant-Based Biotechnology
Products, that examined the potential alter-
native applications for tobacco crops that
have surfaced from research by biotechnol-
ogy companies. The report found that,
while the economicpotential ofsuch appli-
cations is considerable, investments in
research and development must be made
for them to succeed.
Davies says the THRI continues to
emphasize partnerships with industry
because "the one limiting factor to getting
molecular farming to take off is the end-
user interest." He says the work is begin-
ning to pay off, as more companies are
calling and showing interest in the THRI.
"The results are more encouraging all the
time, and interest ispicking up," he says.
Ifthe research demonstrates that trans-
genic tobacco products are effective and
that their production can be profitable,
researchers and biotechnology companies
will next have to persuade tobacco farmers
to grow the modified plants. "It's a matter
of the tobacco farmers understanding that
they can make more money by producing
medically useful compounds than medical-
lyharmful compounds," says Daniell.
Many tobacco farmers, unsure of their
fate, seem open to suggestions and new uses
I~~~~~~~~~~~~
Molecularfanning. Researchers atthe University
of Central Florida have expressed biopolymers in
tobacco chloroplasts that can be used to develop
,environmentallyfriendly plastics.
for their crops. "We favor the use oftobac-
co wherever it can be best used," says J. T.
Bunn, executive vice president of the Leaf
Tobacco Exporters Association, which rep-
resents members who purchase, process,
and deliver leaf tobacco to manufacturers.
"Ifit can be used for [the development of]
pharmaceuticals-great. It's a genetic
guinea pig right now, and the more
research we have on tobacco, the better off
we all are." Asked if his organization's
members will be open to new uses for
tobacco plants, Bunn says, "Given the
opportunity to produce tobacco, yes, they
will. It'sjust thatsimple."
Brandy E. Fisher
CMs'e e a: g
Daniell H, Chittibabu G, McPherson DT, ZhangX, XuJ, UrryD. Hyperexpression ofa
synthetic protein-based polymer gene. Methods Mol Biol 63:359-371 (1997).
Daniell H, Chittibabu G. Biopolymer production in microorganisms and plants. Chem
Ind 14:555-560 (1997).
Kutchan TM. Alkaloid biosynthesis-the basis for metabolic engineering of medicinal
plants. Plant Cell 7:1059-1070 (1995).
Owen MRL, Pen J, eds. Transgenic plants: a production system for industrial and phar-
maceutical proteins. NewYork:John Wiley & Sons, 1996.
Environmental Health Perspectives * Volume 107, Number 4, April 1999 A 209